Hisashi Ohta

COSMOS-3: The Third Generation Telescope Control Software System of Nobeyama Radio Observatory

Kiyoshi Morita, M. Nakai, Tomoichi Takahashi, 2003 .

Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human

Hisashi Ohta, Koen Van Laere, Osamu Okamoto, 2013, NeuroImage.

Characterization of [18F]Y1-973, a novel PET tracer for the neuropeptide Y Y1 receptor (NPY Y1), in rhesus monkey

Hisashi Ohta, Richard Hargreaves, Hong Fan, 2010, NeuroImage.

Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor

Hisashi Ohta, Mangay Williams, Richard Hargreaves, 2011, NeuroImage.

Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)

Hisashi Ohta, Hiroshi Kawamoto, Satoru Ito, 2007, Journal of Pharmacology and Experimental Therapeutics.

A novel class of cycloalkano[b]pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channel.

Hisashi Ohta, Hiroshi Kawamoto, Satoshi Ozaki, 2008, Journal of medicinal chemistry.

2-Cyclohexylcarbonylbenzimidazoles as potent, orally available and brain-penetrable opioid receptor-like 1 (ORL1) antagonists.

Hisashi Ohta, Hiroshi Kawamoto, Satoshi Ozaki, 2009, Bioorganic & medicinal chemistry letters.

Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S,4R)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]piperidine as clinical candidate.

Hisashi Ohta, Hiroshi Kawamoto, Satoshi Ozaki, 2009, Journal of medicinal chemistry.